title: [New patterns of substance use and abuse among French adolescents, a knowledge synthesis].
abstract: OBJECTIVE
  There have been significant changes in adolescent consumption habits over the past fifteen years. New molecules have been synthesized, new devices created and a number of products have increased in popularity; and as a result clinicians sometimes lack information. We chose to focus on this population because of its vulnerability, as adolescents show low sensitivity to long-term outcomes of their actions and may be easily influenced by peers as regards experimentation of new drugs. The most consumed products by adolescents in France are tobacco, alcohol and cannabis with the physiological effects and consumption patterns of these drugs well documented. The purpose of this review is to identify and describe other products that are frequently used by adolescents to get high, to increase performance, for purposes of self-medication or because of peer pressure. We summarized the current scientific evidence regarding drug availability, physical and chemical properties, pharmacodynamics and adverse effects.
  
  
  METHODS
  A literature review was conducted from 2000 to 2015 based on Pudmed, Google Scholar and governmental websites, using the following keyword alone or in combination: "adolescent", "new", "misuse", "abuse", "toxicity", "pharmacology" "cocaine", "MDMA", "inhalant", "poppers", "magic mushroom", "psilocybin", "designer drug", "legal high", "smart drug", "cathinone", "mephedrone", "cannabinoid", "prescription drug", "codeine", "opioid", "methylphenidate", "cough syrup", "purple drank".
  
  
  RESULTS
  New products, including synthetic cannabis, cathinone or purple drank seem to be the most dangerous. They are easily accessible and may lead to short-term severe or lethal complications. Other substances do not pose a major short-term health risk by themselves. However, their consumption may be an indication of other unhealthy risk behaviors, such as prescription drug use, which may be related to psychiatric comorbidity. Unfortunately, we do not have enough data to determine the long-term consequences of the use of these substances. Moreover, these products have a strong addictive potential and may be a risk factor for other addictions. For this reason, increased supervision is justified, both for surveillance and reduction of harm.
  
  
  CONCLUSIONS
  Taking care of an adolescent with substance abuse can be difficult. Updated information regarding these new substances and the particular danger they pose to adolescent health is needed. Informed clinicians can provide up to date and accurate information to the patient and family, assess potential risk factors and comorbidities, and provide appropriate support. Furthermore, because of the high prevalence of substance abuse in the adolescent population, systematic screening of adolescent consumption habit is useful to avoid or anticipate complications. Often, problematic substance consumption behaviors are signs of more complicated psychological or psychiatric issues. Substance abuse behaviors will often disappear over time but they can also become a major problem as the adolescent moves into adulthood. If problems persist, consultation with an addiction specialist may be warranted.
authors.affiliation: Service de médecine psychologique pour l'enfant et l'adolescent (MPEA), CHU Saint-Éloi, 80, avenue Augustin-Fliche, 34090 Montpellier, France. Electronic address: gjeanne@chu-montpellier.fr.
authors.forename: G
authors.initials: G
authors.lastname: Jeanne
authors.affiliation: Service de médecine psychologique pour l'enfant et l'adolescent (MPEA), CHU Saint-Éloi, 80, avenue Augustin-Fliche, 34090 Montpellier, France.
authors.forename: D
authors.initials: D
authors.lastname: Purper-Ouakil
authors.affiliation: Service de médecine interne et addictologie, CHU Saint-Éloi, 80, avenue Augustin-Fliche, 34090 Montpellier, France.
authors.forename: H
authors.initials: H
authors.lastname: Rigole
authors.affiliation: Service de médecine psychologique pour l'enfant et l'adolescent (MPEA), CHU Saint-Éloi, 80, avenue Augustin-Fliche, 34090 Montpellier, France. Electronic address: n-franc@chu-montpellier.fr.
authors.forename: N
authors.initials: N
authors.lastname: Franc
mesh_terms: D000293:Adolescent; D015198:Designer Drugs; D005260:Female; D005602:France / Q000453:epidemiology; D006801:Humans; D008297:Male; D015995:Prevalence; D012307:Risk Factors; D012907:Smoking / Q000453:epidemiology; D019966:Substance-Related Disorders / Q000453:epidemiology* / Q000523:psychology
chemical_list: D015198:Designer Drugs
keywords: Addiction; Addictive behavior; Adolescent; Substance-related disorders; Troubles liés à une substance